125
Views
10
CrossRef citations to date
0
Altmetric
Theme: Demyelinating diseases - Review

Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomes

, &
Pages 433-440 | Published online: 09 Jan 2014

References

  • Chitnis T, Glanz B, Jaffin S, Healy B. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult. Scler.15(5), 627–631 (2009).
  • Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D. Early onset multiple sclerosis: a longitudinal study. Neurology59(7), 1006–1010 (2002).
  • Simone IL, Carrara D, Tortorella C et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology59(12), 1922–1928 (2002).
  • Kennedy J, O’Connor P, Sadovnick AD, Perara M, Yee I, Banwell B. Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry. Neuroepidemiology26(3), 162–167 (2006).
  • Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol.7(12), 1139–1151 (2008).
  • Mikaeloff Y, Adamsbaum C, Husson B et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain127(Pt 9), 1942–1947 (2004).
  • Mikaeloff Y, Caridade G, Husson B, Suissa S, Tardieu M. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur. J. Paediatr. Neurol.11(2), 90–95 (2007).
  • Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology68(16 Suppl. 2), S7–S12 (2007).
  • Hahn CD, Shroff MM, Blaser SI, Banwell BL. MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort. Neurology62(5), 806–808 (2004).
  • Callen DJ, Shroff MM, Branson HM et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology72(11), 968–973 (2009).
  • Callen DJ, Shroff MM, Branson HM et al. MRI in the diagnosis of pediatric multiple sclerosis. Neurology72(11), 961–967 (2009).
  • Neuteboom RF, Boon M, Catsman Berrevoets CE et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology71(13), 967–973 (2008).
  • Ketelslegers IA, Neuteboom RF, Boon M, Catsman-Berrevoets CE, Hintzen RQ. A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology74(18), 1412–1415 (2010).
  • Waubant E, Chabas D, Okuda DT et al. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch. Neurol.66(8), 967–971 (2009).
  • Yeh EA, Weinstock-Guttman B, Ramanathan M et al. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain132(Pt 12), 3392–3400 (2009).
  • Zivadinov R, Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis. J. Neuroimaging14, S27–S35 (2004).
  • Mesaros S, Rocca MA, Absinta M et al. Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology70(13 Pt 2), 1107–1112 (2008).
  • Rocca MA, Absinta M, Ghezzi A, Moiola L, Comi G, Filippi M. Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients?. Hum. Brain Mapp.30(9), 2844–2851 (2008).
  • Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch. Neurol.66(1), 54–59 (2009).
  • Ruggieri M, Polizzi A, Pavone L, Grimaldi LM. Multiple sclerosis in children under 6 years of age. Neurology53(3), 478–484 (1999).
  • Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol.13(3), 227–231 (1983).
  • Renoux C, Vukusic S, Mikaeloff Y et al. Natural history of multiple sclerosis with childhood onset. N. Engl. J. Med.356(25), 2603–2613 (2007).
  • Tortorella P, Rocca MA, Mezzapesa DM et al. MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis. J. Neurol.253(7), 903–907 (2006).
  • Rocca MA, Absinta M, Moiola L et al. Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing–remitting multiple sclerosis. Radiology254(2), 541–550 (2010).
  • Giedd JN, Blumenthal J, Jeffries NO et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat. Neurosci.2(10), 861–863 (1999).
  • Sowell ER, Trauner DA, Gamst A, Jernigan TL. Development of cortical and subcortical brain structures in childhood and adolescence: a structural MRI study. Dev. Med. Child Neurol.44(1), 4–16 (2002).
  • Anderson V, Spencer-Smith M, Leventer R et al. Childhood brain insult: can age at insult help us predict outcome?. Brain132(Pt 1), 45–56 (2009).
  • Rocca MA, Absinta M, Valsasina P et al. Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study. Hum. Brain Mapp.30(8), 2412–2425 (2008).
  • Amato MP, Goretti B, Ghezzi A et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology70(20), 1891–1897 (2008).
  • Banwell BL, Anderson PE. The cognitive burden of multiple sclerosis in children. Neurology64(5), 891–894 (2005).
  • Wechsler D. Wechsler Abbreviated Scale of Intelligence. Pearson, Inc., TX, USA (1999).
  • Beery K, Beery N. The Beery–Buktenica Developmental Test of Visual-Motor Integration. Pearson, Inc., TX, USA (2006).
  • Martin N. Test of Visual Perceptual Skills. PAR, Inc., FL, USA (2006).
  • Matthews CG, Klove K. Instruction Manual for the Adult Neuropsychology Test Battery. University of Wisconsin Medical School, WI, USA (1964).
  • Delis DC, Kramer J. California Verbal Learning Test – Children’s Version. The Psychological Corporation, TX, USA (1994).
  • Benedict RHB. Brief Visuospatial Memory Test – Revised. Psychological Assessment Resources, FL, USA (1997).
  • Brownell R. Expressive One-Word Picture Vocabulary Test. Academic Therapy Publications, CA, USA (2000).
  • Delis DC, Kaplan E. Delis–Kaplan Executive Function System. The Psychological Corporation, TX, USA (2001).
  • Conners KC. Conners’ Continuous Performance Test II. Multi-Health Systems, NY, USA (2000).
  • Anderson PE, Anderson V. Standardization of the Contingency Naming Test (CNT) for school-aged children: a measure of reactive flexibility. Clin. Neuropsychol. Assess.1, 247–273 (2000).
  • McGrew KS, Woodcock RW. Technical Manual: Woodcock-Johnson III. Riverside Publishing, IL, USA (2001).
  • Wechsler D. Wechler Individual Achievement Test, Second Edition. The Psychological Corp., A Harcourt Assessment Company, TX, USA (2002).
  • Varni J, Seid M, Kurtin P. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory Version 4.0 generic core scales in healthy and patient populations. Med. Care39, 800–812 (2001).
  • Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior Rating Inventory of Executive Function. Psychological Assessment Resources Inc., FL, USA (2000).
  • Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology41(5), 685–691 (1991).
  • Pelosi L, Geesken JM, Holly M, Hayward M, Blumhardt LD. Working memory impairment in early multiple sclerosis. Evidence from an event-related potential study of patients with clinically isolated myelopathy. Brain120(Pt 11), 2039–2058 (1997).
  • Piras MR, Magnano I, Canu ED et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J. Neurol. Neurosurg. Psychiatry74(7), 878–885 (2003).
  • MacAllister WS, Belman AL, Milazzo M et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology64(8), 1422–1425 (2005).
  • MacAllister WS, Christodoulou C, Milazzo M, Krupp LB. Longitudinal neuropsychological assessment in pediatric multiple sclerosis. Dev. Neuropsychol.32(2), 625–644 (2007).
  • Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch. Neurol.52(2), 168–172 (1995).
  • Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch. Neurol.58(10), 1602–1606 (2001).
  • Amato M, Gordetti B, Ghezzi A et al. Cognitive and psychosocial features of childhood and juvenile MS: a reappraisal after 2 years. Neurology72(Suppl. 1), A97 (2009).
  • MacAllister WS, Christodoulou C, Troxell R et al. Fatigue and quality of life in pediatric multiple sclerosis. Mult. Scler.15(12), 1502–1508 (2009).
  • Mowry E, Julian L, Chabas D et al. Health-related qulaity of life is reduced in children with early multiple sclerosis. Mult. Scler.14(Suppl. 1), S147 (2008).
  • Pohl D, Rostasy K, Gartner J, Hanefeld F. Treatment of early onset multiple sclerosis with subcutaneous interferon β-1a. Neurology64(5), 888–890 (2005).
  • Ghezzi A. Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study. Neurol. Sci.26(Suppl. 4), S183–S186 (2005).
  • Banwell B, Reder AT, Krupp L et al. Safety and tolerability of interferon β-1b in pediatric multiple sclerosis. Neurology66(4), 472–476 (2006).
  • Ghezzi A, Amato MP, Capobianco M et al. Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Mult. Scler.11(4), 420–424 (2005).
  • Waubant E, Hietpas J, Stewart T et al. Interferon β-1a in children with multiple sclerosis is well tolerated. Neuropediatrics32(4), 211–213 (2001).
  • Fischer JS, Priore RL, Jacobs LD et al. Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann. Neurol.48(6), 885–892 (2000).
  • Barak Y, Achiron A. Effect of interferon-β-1b on cognitive functions in multiple sclerosis. Eur. Neurol.47(1), 11–14 (2002).
  • Kappos L, Freedman MS, Polman CH et al. Long-term effect of early treatment with interferon β-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the Phase 3 BENEFIT trial. Lancet Neurol.8(11), 987–997 (2009).
  • Weinstein A, Schwid SR, Schiffer RB, McDermott MP, Giang DW, Goodman AD. Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch. Neurol.56(3), 319–324 (1999).
  • Cernich AN, Kurtz SM, Mordecai KL, Ryan PB. Cognitive rehabilitation in traumatic brain injury. Curr. Treat. Options Neurol.12(5), 412–423 (2010).
  • Portaccio E, Goretti B, Zipoli V et al. Cognitive rehabilitation in children and adolescents with multiple sclerosis. Neurol. Sci.31(Suppl. 2), S275–S278 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.